Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Hepatol. Jan 27, 2018; 10(1): 41-50
Published online Jan 27, 2018. doi: 10.4254/wjh.v10.i1.41
Table 2 Underlying etiologies of liver disease per year (frequencies)
HCVHBVAlcoholNASHCCCholestasisAIOther1Total
200924 (34.3)7 (10.0)18 (25.7)3 (4.3)9 (12.9)009 (12.9)70
201051 (48.6)5 (4.8)16 (15.2)5 (4.8)12 (11.4)3 (2.9)1 (0.9)12 (11.5)105
201134 (35.6)5 (5.3)26 (27.4)10 (10.5)9 (9.5)1 (1.0)1 (1.0)7 (6.4)95
201243 (38.0)5 (4.4)21 (18.6)14 (12.4)10 (8.8)3 (2.6)05 (8.0)113
201343 (33.1)9 (6.9)24 (18.5)14 (10.8)17 (13.1)2 (1.5)1 (0.8)13 (10.0)130
201443 (36.7)4 (3.4)22 (18.8)15 (12.8)9 (7.7)3 (2.6)016 (13.7)117
201524 (30.8)3 (3.8)20 (25.6)20 (25.6)2 (2.6)1 (1.3)04 (5.2)78
Total (%)262 (37.0)38 (5.4)147 (20.8)81 (11.4)68 (9.6)13 (1.8)3 (0.4)60 (9.9)708

  • Citation: Piñero F, Pages J, Marciano S, Fernández N, Silva J, Anders M, Zerega A, Ridruejo E, Ameigeiras B, D’Amico C, Gaite L, Bermúdez C, Cobos M, Rosales C, Romero G, McCormack L, Reggiardo V, Colombato L, Gadano A, Silva M. Fatty liver disease, an emerging etiology of hepatocellular carcinoma in Argentina. World J Hepatol 2018; 10(1): 41-50
  • URL: https://www.wjgnet.com/1948-5182/full/v10/i1/41.htm
  • DOI: https://dx.doi.org/10.4254/wjh.v10.i1.41